Using the newly-developed PSMA-EV sandwich ELISA, we demonstrated that the PSMA-EV levels were higher in metastatic PC and CRPC patients as well as in metastatic RCC patients, suggesting their usefulness for diagnosis and monitoring of PC and RCC. Here, FOLH1 is linked to pachyonychia congenita.